Duke University Hospital Endocrinology, Diabetes, and Metabolism

Topics

• Diabetes Treatment and Management 209
• Lipoproteins and Cardiovascular Health 80
• Bariatric Surgery and Outcomes 45
• Bone health and osteoporosis research 44
• Regulation of Appetite and Obesity 44
• Blood Pressure and Hypertension Studies 42
• Diet and metabolism studies 42
• Diabetes, Cardiovascular Risks, and Lipoproteins 40
• Diabetes Management and Research 39
• Diabetes Management and Education 38
• Pancreatic function and diabetes 34
• Hyperglycemia and glycemic control in critically ill and hospitalized patients 28

Most cited

1. Empagliflozin in Patients with Chronic Kidney Disease.

   The New England journal of medicine · 2023 · 2,075 citations · Jennifer Green

2. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

   Diabetes care · 2022 · 1,440 citations · Jennifer Green

3. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

   Diabetologia · 2022 · 744 citations · Jennifer Green

4. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.

   The New England journal of medicine · 2025 · 232 citations · Jennifer Green

5. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.

   The New England journal of medicine · 2025 · 125 citations · David D'Alessio

6. Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.

   American heart journal · 2024 · 204 citations ·